Apr 22, 2026 09:00AM

Mar 5, 2026 11:05AM

Aug 26, 2025 10:29PM

Sep 5, 2024 11:56AM

Sep 5, 2024 11:54AM

Apr 15, 2024 06:00AM

Feb 15, 2023 06:00AM Immuron CEO, Steven Lydeamore to host an investor webinar

Jan 25, 2023 06:03AM

Jan 25, 2023 06:00AM

Dec 23, 2022 06:01AM

Dec 23, 2022 06:00AM

Dec 5, 2022 06:00AM

Oct 4, 2022 06:02AM

Oct 4, 2022 06:00AM Immuron Executes Travelan Clinical Trial Agreement with US-based Pharmaron

Jul 26, 2022 06:07AM

Jul 26, 2022 06:00AM

May 11, 2022 06:00AM

May 6, 2022 05:47AM

May 5, 2022 08:22PM

Apr 27, 2022 06:00AM

Apr 19, 2022 07:33AM Immuron new MTEC project proposal “Development of Oral Immunotherapy for the Prevention of Bacterial Diarrheal Disease”

Nov 10, 2021 06:00AM

Jan 11, 2021 06:00AM

Nov 24, 2020 06:00AM

Nov 11, 2020 06:16AM

Nov 11, 2020 06:00AM

Oct 12, 2020 06:00AM

Jul 23, 2020 12:45PM Immuron Limited Announces Closing of $20.0 Million Registered Direct Offering

Jul 21, 2020 08:47AM

Jul 21, 2020 08:45AM

Jul 21, 2020 07:04AM

Jul 21, 2020 07:00AM

Jul 20, 2020 06:00AM

Jun 19, 2020 06:00AM

Jun 9, 2020 06:18AM Immuron Ltd. (IMRN) Reports NMRC Requested Pre-IND with FDA for Guidance on Two Ph. II Trials to Prevent Acute Infectious Diarrhea

Jun 9, 2020 06:00AM

Apr 20, 2020 06:00AM

Mar 25, 2020 06:07AM

Mar 25, 2020 06:00AM

Mar 3, 2020 07:00AM

Feb 3, 2020 07:30AM

Feb 3, 2020 07:30AM Immuron’s Technology Platform of Treatments in the Age of the Coronavirus Outbreak

Jan 28, 2020 08:30AM

Nov 21, 2019 07:08AM

Nov 21, 2019 07:00AM

Nov 4, 2019 11:30AM

Oct 2, 2019 09:00AM

Aug 16, 2019 06:00AM

Aug 8, 2019 12:01PM Immuron (IMRN) Announces Results in Severe Alcoholic Hepatitis Clinical Trial

Aug 8, 2019 12:00PM

322,996 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All